Cell line · CVCL_0065
Papers157
1 to 20 of 157
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Comparison of Chemical Components, Anti-Inflammatory Effect and Cytotoxicity to Cancer Cells of Essential Oils From Different Parts of Celosia argentea. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NETs drive CD4⁺ T cell dysfunction in sepsis via mitochondrial ROS and impaired calcium signalling. | Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ionomycin suppresses cancer cell growth by disrupting mitochondrial transcription. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ETV6 Rearrangement Suppresses CDKN1B Transcription by Disrupting an Intragenic Super-enhancer in Acute Lymphoblastic Leukemia. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Production of virus-like particles with AsCas12a nuclease and CMV-driven crRNA for mammalian genome editing. | Front Genome Ed | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Synergistic Induction of Caspase-8-Mediated Leukaemic Cell Death by Fisetin and Pinocembrin. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription. | Res Sq | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chemical Markers and Bioactivity of Algerian Royal Jelly: Influence of Bee Subspecies, Geography, and Lyophilization. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Exosome-like biogenesis from the Golgi releases extracellular vesicles lacking conventional tetraspanins that mediate immune evasion in cancer. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Optimizing Zirconium-89 labeling for chimeric antigen receptor T cell PET imaging by comparing desferrioxamine and oxine. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inflammatory CD4+ T cells can waive NRF2-dependent SLC7A11-mediated cystine uptake by using ASCT1. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Development of human monoclonal antibodies against TARM1 by yeast display. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Nanoparticle-Integrated Complete Manufacturing Pipeline of Chemically Engineered Exosomes. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hsa_circ_0000313/miR-1224-3p/MKNK2 Axis Modulates CD4+ T Cells by Activating p38 MAPK Signaling in Myasthenia Gravis. | Mediators Inflamm | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Folate promotes colorectal cancer progression by impairing CD8+ T cell function and recruitment via SLC19A1/p-AKT/NOTCH1 axis and CCL5 downregulation. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0065/papers